Cargando…
Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review
Clostridium difficile (C. difficile) is a common cause of antibiotic-associated diarrhea (AAD), being responsible for 15-25% of all AAD cases. The purpose of this literature review is to determine the cost-effectiveness of fecal microbiota transplantation (FMT) and how it compares in this regard t...
Autores principales: | Arbel, Leor T, Hsu, Edmund, McNally, Keegan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652885/ https://www.ncbi.nlm.nih.gov/pubmed/29067223 http://dx.doi.org/10.7759/cureus.1599 |
Ejemplares similares
-
Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017) -
Safe prevention of Clostridium difficile using infectious disease guidelines at an urban hospital in North Carolina
por: Davies, Eileen, et al.
Publicado: (2022) -
Mind and body: physical health monitoring in clozapine treatment
por: Abdelreheem, Moataz, et al.
Publicado: (2021) -
Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Song, Yang, et al.
Publicado: (2013) -
Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection
por: Kim, Kyeong Ok, et al.
Publicado: (2019)